What is the price target for AVAH stock?
17 analysts have analysed AVAH and the average price target is 10.09 USD. This implies a price increase of 48.99% is expected in the next year compared to the current price of 6.77.
AVEANNA HEALTHCARE HOLDINGS (AVAH) Forecast, Price Target & Analyst Ratings
NASDAQ:AVAH • US05356F1057
Current stock price
6.77 USD
+0.06 (+0.89%)
At close:
6.764 USD
-0.01 (-0.09%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AVEANNA HEALTHCARE HOLDINGS (AVAH).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.13
- Revenue Estimate
- 625.45M
Price Target Details & History
Consensus Price Target and Range
Mean target
$10.09
Upside
+ 48.99%
From current price of $6.77 to mean target of $10.09, Based on 17 analyst forecasts
Low
$7.07
Median
$10.20
High
$13.65
Price Target Revisions
1 Month
-11.00%
3 Months
-7.77%
Price Target Summary
17 Wall Street analysts provided a forecast for the next 12 months for AVAH. The average price target is 10.09 USD. This implies a price increase of 48.99% is expected in the next year compared to the current price of 6.77.
The average price target has been revised downward by 7.77% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
78.82%
AVAH was analyzed by 17 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about AVAH.
In the previous month the buy percentage consensus was at a similar level.
AVAH was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-13 | Truist Securities | Maintains | Hold -> Hold |
| 2026-03-25 | Barclays | Maintains | Overweight -> Overweight |
| 2026-03-23 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-03-20 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-03-20 | Truist Securities | Maintains | Hold -> Hold |
| 2026-01-16 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-15 | UBS | Maintains | Neutral -> Neutral |
| 2026-01-15 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-12-08 | William Blair | Initiate | Outperform |
| 2025-11-13 | BMO Capital | Initiate | Outperform |
| 2025-11-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-07 | Truist Securities | Maintains | Hold -> Hold |
| 2025-10-28 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-24 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-10-13 | UBS | Maintains | Neutral -> Neutral |
| 2025-09-18 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2025-08-19 | UBS | Upgrade | Sell -> Neutral |
| 2025-08-19 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-08-12 | UBS | Maintains | Sell -> Sell |
| 2025-08-11 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2025-07-21 | Jefferies | Upgrade | Hold -> Buy |
| 2025-07-16 | Truist Securities | Maintains | Hold -> Hold |
| 2025-07-02 | Barclays | Initiate | Equal-Weight |
| 2025-05-09 | UBS | Maintains | Sell -> Sell |
| 2025-04-11 | Truist Securities | Maintains | Hold -> Hold |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.13
- Revenue Estimate
- 625.45M
- Revenue Q2Q
- 11.84%
- EPS Q2Q
- 28.62%
- Number of Analysts
- 12
Next Earnings Revisions
Revenue (1 Month)
-0.67%
Revenue (3 Months)
0.09%
EPS (1 Month)
3.64%
EPS (3 Months)
-5.90%
Next Earnings Summary
AVAH is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is 0.13 USD and the consensus revenue estimate is 625.45M USD.
The next earnings revenue estimate has been revised upward by 0.09% in the past 3 months.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.895B 6.02% | 2.025B 6.82% | 2.433B 20.19% | 2.611B 7.31% | 2.757B 5.59% | 2.894B 4.97% | |
| EBITDA YoY % growth | 127.452M 134.29% | 152.055M 19.30% | 270.814M 78.10% | 327.81M 21.05% | 350.44M 6.90% | 372.69M 6.35% | |
| EBIT YoY % growth | 113.674M 243.43% | 141.277M 24.28% | 260.276M 84.23% | 307.45M 18.12% | 327.25M 6.44% | N/A | |
| Operating Margin | 6.00% | 6.98% | 10.70% | 11.78% | 11.87% | N/A | |
| EPS YoY % growth | -0.12 -1,300.00% | 0.05 141.67% | 0.60 1,100.00% | 0.64 6.51% | 0.71 11.49% | 0.78 9.27% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.13 28.62% | 0.16 -10.47% | 0.17 12.20% | 0.18 7.40% | 0.15 18.95% | 0.17 7.59% | 0.19 15.15% | 0.21 15.46% | 0.12 -20.00% | 0.18 5.88% | 0.19 | 0.20 -3.23% |
| Revenue Q2Q % growth | 625.45M 11.84% | 638.34M 8.28% | 661.91M 6.43% | 685.07M 3.41% | 673.6M 7.70% | 679.06M 6.38% | 697.27M 5.34% | 723M 5.54% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 72.959M 33.87% | 81.529M -8.03% | 84.188M 39.81% | 89.14M 7.31% | 81.381M 11.54% | 86.356M 5.92% | 90.247M 7.20% | 97.081M 8.91% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 68.525M 32.01% | 77.629M -6.96% | 80.111M 52.86% | 85.005M 17.20% | 74.46M 8.66% | 80.478M 3.67% | 82.076M 2.45% | 89.93M 5.79% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
9.07%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
5.47%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
7.53%
EBIT Next 5 Year
N/A
AVEANNA HEALTHCARE HOLDINGS / AVAH Forecast FAQ
What is the next earnings date for AVAH stock?
AVEANNA HEALTHCARE HOLDINGS (AVAH) will report earnings on 2026-05-07, before the market open.
Can you provide the consensus estimates for AVEANNA HEALTHCARE HOLDINGS next earnings?
The consensus EPS estimate for the next earnings of AVEANNA HEALTHCARE HOLDINGS (AVAH) is 0.13 USD and the consensus revenue estimate is 625.45M USD.
What is the consensus rating for AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?
The consensus rating for AVEANNA HEALTHCARE HOLDINGS (AVAH) is 78.8235 / 100 . This indicates that analysts generally have a positive outlook on the stock.